Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EB02	MIRATA	G	Erlotinib (HCl) - 100mg	100mg	Tablet, film coated	77,379,009 L.L
L01DB07	MITOXANTRON EBEWE	G	Mitoxantrone - 20mg/10ml	20mg/10ml	Injectable concentrated solution	11,064,120 L.L
L01BC07	MATURUS	G	Azacitidine - 100mg	100mg	Injectable lyophilised powder	9,401,575 L.L
L01BB04	MAVENCLAD	B	Cladribine - 10mg	10mg	Tablet	200,244,812 L.L
L01BA01	METHOTREXAT EBEWE	G	Methotrexate - 500mg	500mg	Injectable solution	1,842,408 L.L
J07BD52	MEASLES, MUMPS AND RUBELLA VACCINE LIVE ATTENUATED (FREEZE-DRIED) MMR	G	Rubella virus live attenuated - ≥1000CCID50 /0.5ml, Mumps virus live attenuated - ≥5000CCID50 /0.5ml, Measles virus live attenuated - ≥1000CCID50 /0.5ml		Injectable freeze dried powder + diluent	739,113 L.L
J07BD52	M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE)	B	Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated -		Injectable solution+diluent	12,924,401 L.L
J07AH08	MENQUADFI	G	Meningococcal (serogroups A, C, W and Y) conjugate vaccine -		Injectable solution	4,859,334 L.L
J07AH08	MENACTRA MENINGOCOCCAL POLYSACCHARIDE DIPHTERIA TOXOID CONJUGATE VACCINE	B	Meningococcal Polysaccharides (serogroups A, C, Y and W-135) - 4mcg/0.5ml each, Diphteria Toxoid Protein - 48mcg/0.5ml		Injectable solution	6,144,048 L.L
J07AH	MENFIVE	G	Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine -		Injectable freeze dried powder + diluent	3,527,587 L.L
J02AX05	MEGMENTO	G	Micafungin (sodium) - 100mg	100mg	Injectable powder for solution	17,158,569 L.L
J02AX05	MEGMENTO	G	Micafungin (sodium) - 50mg	50mg	Injectable powder for solution	9,530,364 L.L
J02AX05	MYCAMINE	B	Micafungin (sodium) - 50mg	50mg	Injectable lyophilised powder for solution	13,170,341 L.L
J02AC01	MYXEN	G	Fluconazole - 150mg	150mg	Tablet	255,970 L.L
J02AC01	MYXEN	G	Fluconazole - 50mg	50mg	Tablet	755,112 L.L
J02AC01	MYXEN	G	Fluconazole - 50mg/5ml	50mg/5ml	Granules for suspension	793,507 L.L
J01XX01	MONUROL	B	Fosfomycine (trométamol) - 3g	3g	Granules for solution	571,133 L.L
J01RA	MEDSPIRAGYL	G	Metronidazole - 125mg, Spiramycin - 750,000IU		Tablet, scored	474,824 L.L
J01MA14	MOFLOXINE	G	Moxifloxacin (HCl) - 400mg/250ml	400mg/250ml	Injectable solution	1,638,144 L.L
J01MA12	MATADOR	G	Levofloxacin - 750mg	750mg	Tablet, film coated	1,126,140 L.L
J01MA12	MATADOR	G	Levofloxacin - 500mg	500mg	Tablet, film coated	787,492 L.L
J01GB06	MIACIN	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	2,015,764 L.L
J01DH02	MIRAN	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	819,744 L.L
J01DH02	MEROZAN	G	Meropenem - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MEROPENEM/ ANFARM	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MEROPENEM PANPHARMA	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	7,278,513 L.L
J01DH02	MEROPENEM MEDIS	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MEROPENEM LABATEC	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	7,278,513 L.L
J01DH02	MEROLIN	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	2,402,668 L.L
J01DH02	MERONEM	B	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	10,398,061 L.L

...